HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surgery for peptic ulceration associated with hypergastrinaemia.

Abstract
Between 1971 and 1983, 31 males and 13 females were found to have peptic ulceration associated with hypergastrinaemia. An antral G-cell lesion was present in 11 (25 per cent) and a gastrinoma in 14 (32 per cent). There were 11 patients with multiple endocrine adenomatosis (MEA) (25 per cent) and 4 (9 per cent) with primary hyperparathyroidism. Four patients (9 per cent) were unclassified. Length of history and level of gastrin did not differentiate between the groups and an average of 2.5 operations was performed per patient, while the overall mortality was 27.3 per cent. The patients with G-cell lesions were significantly younger than all the other groups (P less than 0.01). Partial gastrectomy adequately treated G-cell hyperplasia. Total gastrectomy was required to treat pancreatic gastrinomata but additional pancreatic resection did not improve the outcome. In MEA, parathyroidectomy did not influence the treatment of a gastrinoma. This is the first recorded experience of surgery for hypergastrinaemia in the United Kingdom and the outcome of such a retrospective study may be a guide to the future management of these conditions.
AuthorsC G Clark, N L Chowcat, M R Lewin, J M Gilbert, J S Gelister, P B Boulos
JournalThe British journal of surgery (Br J Surg) Vol. 73 Issue 4 Pg. 248-52 (Apr 1986) ISSN: 0007-1323 [Print] England
PMID2870756 (Publication Type: Journal Article)
Chemical References
  • Gastrins
Topics
  • Adenoma, Islet Cell (surgery)
  • Adolescent
  • Adult
  • Aged
  • Female
  • Gastrectomy
  • Gastrins (blood)
  • Humans
  • Hyperparathyroidism (surgery)
  • Male
  • Middle Aged
  • Multiple Endocrine Neoplasia (surgery)
  • Pancreatectomy
  • Pancreatic Neoplasms (surgery)
  • Peptic Ulcer (surgery)
  • Zollinger-Ellison Syndrome (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: